Symbols

PGNY

Progyny·NASDAQ

--(--)

Signals Analysis

Bullish signal 3

Bearish signal 1

Consensus Rating "Buy"

Ample Liquidity

EPS Beats Expectation

Revenue Below Expectations

Key Stats

0.0000DAY`S RANGE0.0000

0.000052 WK RANGE0.0000

Open

0.0000

Prev.Close

0.0000

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

0.0000

Low

0.0000

52 Week High

0.0000

52 Week Low

0.0000

About PGNY

Progyny, Inc.

A leading fertility benefits management company

Industry

Healthcare Providers and Services

Established Date

04/03/2008

Listing Date

10/25/2019

Exchange

NASDAQ Stock Exchange

Full-time Employees

835

Fiscal Year Ends

12-31

Website

www.progyny.com

Security Type

Common stock

Office address

1359 Broadway, New York, New York 10018

Business

Introduction

Progyny, Inc., was incorporated in Delaware on April 3, 2008. The company is a global leader in women's health and family building solutions, providing transformative fertility, pregnancy and menopause benefits. It serves a large number of employer clients through a specially built platform that connects members with a network of first-class experts.

Company Financials

EPS

PGNY has released its 2025 Q4 earnings. EPS was reported at 0.48, versus the expected 0.14, beating expectations. The chart below visualizes how PGNY has performed over recent quarters, highlighting trends in earnings surprises.

Revenue & Expenses

PGNY has released its 2025 Q4 earnings report, with revenue of 318.40M, reflecting a YoY change of 6.69%, and net profit of 12.48M, showing a YoY change of 18.54%. The Sankey diagram below clearly presents PGNY's revenue sources and cost distribution.